Literature DB >> 18423800

Synthesis, cytotoxicity and apoptosis of naphthalimide polyamine conjugates as antitumor agents.

Zhi-yong Tian1, Song-qiang Xie, Yao-wu Du, Yuan-fang Ma, Jin Zhao, Wen-yuan Gao, Chao-jie Wang.   

Abstract

Several naphthalimide polyamine conjugates were synthesized and evaluated for in vitro cytotoxicity against human leukemia K562, murine melanoma B16, Chinese hamster ovary CHO cell lines. Both triamine moieties and the length of spacers were crucial in elevating the potency of 1,8-naphthalimide. The typical compounds 5a and 5d exhibited excellent cell selectivity to cancer cells through the human hepatoma BEL-7402 and human normal hepatocyte QSG-7701 screens. In addition, 5d could disturb the cell cycle in B16 cells. The research on caspase activity and cytochrome c indicated that 5d could induce B16 cell apoptosis via both the mitochondrial and membrane death receptor pathways, and the Bcl-2 family numbers were involved in the control of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423800     DOI: 10.1016/j.ejmech.2008.02.044

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

1.  COX-2-independent induction of apoptosis by celecoxib and polyamine naphthalimide conjugate mediated by polyamine depression in colorectal cancer cell lines.

Authors:  Song-qiang Xie; Ya-hong Zhang; Qian Li; Jian-hong Wang; Jing-hua Li; Jin Zhao; Chao-jie Wang
Journal:  Int J Colorectal Dis       Date:  2011-12-10       Impact factor: 2.571

2.  Antitumor efficacy and apoptotic activity of substituted chloroalkyl 1H-benz[de]isoquinoline-1,3-diones: a new class of potential antineoplastic agents.

Authors:  Asama Mukherjee; Suva Hazra; Sushanta Dutta; Shanmugavel Muthiah; Dilip Manikrao Mondhe; Parduman Raj Sharma; Shashank Kumar Singh; Ajit Kumar Saxena; Gulam Nabi Qazi; Utpal Sanyal
Journal:  Invest New Drugs       Date:  2010-01-12       Impact factor: 3.850

3.  Novel naphthalimide polyamine derivatives as potential antitumor agents.

Authors:  Robert Seliga; Martina Pilatova; Marek Sarissky; Viktor Viglasky; Martin Walko; Jan Mojzis
Journal:  Mol Biol Rep       Date:  2013-05-03       Impact factor: 2.316

4.  Study on the interaction between the 1,4,5,8-naphthalene diimide-spermine conjugate (NDIS) and DNA using a spectroscopic approach and molecular docking.

Authors:  Zhiyong Tian; Hailong Cui; He Liu; Jun Dong; Huanyang Dong; Luyao Zhao; Xueting Li; Yan Zhang; Yingying Huang; Lina Song; Longxiang Bian; Yuxia Wang; Xuejun Xu; Chaojie Wang
Journal:  Medchemcomm       Date:  2017-09-26       Impact factor: 3.597

5.  6-Nitro-2-(3-hydroxypropyl)-1H-benz[de]isoquinoline-1,3-dione, a potent antitumor agent, induces cell cycle arrest and apoptosis.

Authors:  Asama Mukherjee; Sushanta Dutta; Muthiah Shanmugavel; Dilip M Mondhe; Parduman R Sharma; Shashank K Singh; Ajit K Saxena; Utpal Sanyal
Journal:  J Exp Clin Cancer Res       Date:  2010-12-31

6.  Design, Synthesis and Evaluation of Naphthalimide Derivatives as Potential Anticancer Agents for Hepatocellular Carcinoma.

Authors:  Chaochao Ge; Liping Chang; Ying Zhao; Congcong Chang; Xiaojuan Xu; Haoying He; Yuxia Wang; Fujun Dai; Songqiang Xie; Chaojie Wang
Journal:  Molecules       Date:  2017-02-22       Impact factor: 4.411

7.  Spectroscopic Study on the Interaction between Naphthalimide-Polyamine Conjugates and Bovine Serum Albumin (BSA).

Authors:  Zhi-Yong Tian; Li-Na Song; Yuan Zhao; Feng-Lei Zang; Zhong-Hua Zhao; Nan-Hao Chen; Xue-Jun Xu; Chao-Jie Wang
Journal:  Molecules       Date:  2015-09-11       Impact factor: 4.411

8.  Novel sulphonamide benzoquinazolinones as dual EGFR/HER2 inhibitors, apoptosis inducers and radiosensitizers.

Authors:  Aiten M Soliman; Ali S Alqahtani; Mostafa Ghorab
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

9.  Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma.

Authors:  Laura D Gamble; Michael D Hogarty; Xueyuan Liu; David S Ziegler; Glenn Marshall; Murray D Norris; Michelle Haber
Journal:  Front Oncol       Date:  2012-11-16       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.